Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Seminars in Hematology
|
April 3, 2010
Enhancing existing approaches to peripheral T-cell lymphoma
Francine M Foss
Expert Opinion on Drug Metabolism & Toxicology
|
July 6, 2011
Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma
Francine M Foss
Seminars in Hematology
|
March 22, 2006
The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation
Francine M Foss
Best Practice & Research. Clinical Haematology
|
June 18, 2013
Treatment strategies for peripheral T-cell lymphomas
Francine M Foss
Oncology (Williston Park, N.Y.)
|
January 2, 2010
The importance of accurately characterizing lymphoproliferative disease
Francine M Foss
Cancer Journal (Sudbury, Mass.)
|
March 24, 2011
Molecular predictors of response in aggressive T-cell lymphomas
Francine M Foss
Seminars in Oncology
|
June 18, 2002
Immunologic mechanisms of antitumor activity
Francine M Foss
Journal of Cutaneous Medicine and Surgery
|
September 6, 2003
Extracorporeal photopheresis in the treatment of graft-vs-host disease
Francine M Foss
Best Practice & Research. Clinical Haematology
|
October 21, 2004
Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome
Francine M Foss
Drugs
|
February 20, 2010
Current and emerging treatment strategies for cutaneous T-cell lymphoma
Frederick Lansigan, Francine M Foss
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Seminars in Hematology
|
April 3, 2010
Enhancing existing approaches to peripheral T-cell lymphoma
Francine M Foss
Expert Opinion on Drug Metabolism & Toxicology
|
July 6, 2011
Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma
Francine M Foss
Seminars in Hematology
|
March 22, 2006
The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation
Francine M Foss
Best Practice & Research. Clinical Haematology
|
June 18, 2013
Treatment strategies for peripheral T-cell lymphomas
Francine M Foss
Oncology (Williston Park, N.Y.)
|
January 2, 2010
The importance of accurately characterizing lymphoproliferative disease
Francine M Foss
Cancer Journal (Sudbury, Mass.)
|
March 24, 2011
Molecular predictors of response in aggressive T-cell lymphomas
Francine M Foss
Seminars in Oncology
|
June 18, 2002
Immunologic mechanisms of antitumor activity
Francine M Foss
Journal of Cutaneous Medicine and Surgery
|
September 6, 2003
Extracorporeal photopheresis in the treatment of graft-vs-host disease
Francine M Foss
Best Practice & Research. Clinical Haematology
|
October 21, 2004
Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome
Francine M Foss
Drugs
|
February 20, 2010
Current and emerging treatment strategies for cutaneous T-cell lymphoma
Frederick Lansigan, Francine M Foss
Page
of 8